RESEARCH TRIANGLE PARK – The startups lined up for Venture Day recently in RTP were:

  • Altis BioSystems offers a patented stem cell platform that recreates normal human intestinal tissue in a high throughput and scalable format, which more closely replicates native human biology for drug screening in the pharmaceutical and biotechnology industries.[*Due to unexpected circumstances, Altis Biosystems did not present during Venture Day. However, you can contact this company directly for more information.]
  • Assure Technologies aims to reduce medication errors and keep patients safe throughout their health care journey.
  • Continuous Precision Medicine is working to improve the health and well-being of others by developing more personalized solutions for controlled medication through its innovative and novel precision prescribing technology.
  • Couplet Care offers tools for improving patient safety and clinical efficiency, while promoting positive mother and infant health outcomes. Its first product, a postnatal unit medical infant bassinet, allows the mom to independently access the infant.
  • DNAli Data Technologies aims to revolutionize the digital data storage market by harnessing the incredible density, durability and longevity of DNA to reduce the construction, maintenance, resource and energy costs of data storage facilities by several orders of magnitude.
  • FaunaLabs monitors pet health using technologies like those found in human health wearables. Optical health sensors used in human wearables don’t work on animals with hair or fur, but Fauna Labs invented an optical health sensor that does.
  • Ideal Medical Technologies is a highly innovative medical device company focused on the development and sale of an artificial pancreas system for use in both the ICU and general ward settings.
  • inSoma Bio is striving to build breast implants, personalized lumpectomy molds and repair other soft tissue defects using a person’s own tissue without the need for major reconstructive surgery.
  • IrNEX is developing biomarker imaging software for early detection of cancer treatment responses in days rather than months. It enables differentiation of pseudo-progression from true tumor progression following brain tumor/metastasis treatment.
  • Mente tracks surgical instrument use, capturing a data stream that records how surgery is performed to enable predictability, drive efficiency and increase safety in the operating room.
  • Minatar Therapeutics has developed a mobile mass spectrometer for the simultaneous detection of a wide range of environmental pollutants and contaminants in real-time.
  • Mizar Therapeutics applies transformative live cell imaging technology to accelerate lead validation in drug discovery.
  • Onda Vision Technologies serves people who experience shifts in their hydration levels induced by exertion, mission or medical conditions. The company is developing a wearable hydration system based on bioimpedance to monitor the body’s fluid compartments.
  • SonoVascular is developing a novel, catheter-enabled, multi-mechanism SonoThrombectomy™ system utilizing microbubble-mediated cavitation as the core mechanism of action to treat all types of blood clots more effectively, without the increased risk of bleeding, by uniquely combining multiple mechanisms of action delivered through an integrated intravascular catheter system.
  • SonoVoice is commercializing patent-pending digital voice training technology – the SonoVoice system – that includes a digital device and smartphone app and offers an accessible voice training platform to optimize voice production using proven exercises, vocal function data and original educational content.
  • SplendoHealth offers its AI and mobile app that integrates data from select wearable technologies to provide remote medical grade CRF assessments, including individuals and patients at their local clinic or training facilities — with the eventual goal to provide CRF assessments for anyone at their local pharmacies or in-home.
  • SynchroHealth aims to develop hardware and software solutions for non-invasive detection and acquisition of home-based, longitudinal, healthcare data using remote, Bluetooth low energy enabled technologies for synchronous and asynchronous feedback.
  • Ummino is focused on meeting the sharp rise in consumer demand for fortified food and beverage products. Its patented precision fermentation technology unlocks compounds that are rare in nature to optimize taste and nutrition, transforming commodity ingredients into high value functional foods.
  • URO-1 Medical aims to improve the diagnostic accuracy of prostate biopsy, increasing efficiency in both the urology clinic and the pathology lab, and likely change the standard of care.
  • Vetletics offers modified, proven technology used by human athletes and doctors, and has developed the world’s first dynamic compression device for horses – the EQ Press.

Interested in learning more about Venture Day companies or other companies in the KickStart, Duke New Ventures, NCBiotech or NC State portfolios? Please contact the KickStart team at kickstart@unc.edu, Jeff Welch at Jeff.welch@duke.edu, Vivian Doelling at Vivian_doelling@ncbiotech.org., or Tim Martin at tnmartin@ncsu.edu.

‘Venture Day’ draws a crowd of investors to review a host of promising startups